Hansen Medical, Inc. (NASDAQ: HNSN)

A class action has been filed in the United States District Court for the Northern District of California on behalf of purchasers of Hansen Medical, Inc. (NASDAQ: HNSN) common stock during the period between May 1, 2008 and October 18, 2009 (the “Class Period”). The complaint charges Hansen and certain of its officers and directors with violations of the Securities Exchange Act of 1934. Hansen develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies, including the Sensei® Robotic Catheter System (“Sensei system”), a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart during complex cardiac arrhythmia procedures.

The complaint alleges that during the Class Period, defendants issued materially false and misleading statements regarding the Company’s financial results and compliance with Generally Accepted Accounting Principles. Specifically, the Company improperly recognized revenue associated with the sale of its Sensei systems. As a result of defendants’ false and misleading statements, Hansen’s stock traded at artificially inflated prices during the Class Period, reaching a high of $19.57 per share on May 13, 2008.

Then on October 19, 2009, Hansen announced that it would be restating its financial results for 2008 and for the first and second quarters of 2009 due to its failure to properly account for its revenue as a result of an investigation by the Company’s audit committee. The audit committee’s investigation was prompted by an anonymous “whistleblower” report the Company received in August 2009.

If you are a current shareholder and purchased during period between May 1, 2008 and October 18, 2009 and would like to discuss your options of exercising your rights as a shareholder, please contact us.

Please submit the following information so we can determine if you qualify for the suit. If you don't know all the specific details, partial information is also acceptable.

Personal Information
Name:
Phone #:
E-mail Address:
Stock Information
Do you currently own the stock? Yes   No
Purchase Date:
Quantity Purchased:
Purchase Price Per Share: